Literature DB >> 17440493

Ex vivo programmed macrophages ameliorate experimental chronic inflammatory renal disease.

Y Wang1, Y P Wang, G Zheng, V W S Lee, L Ouyang, D H H Chang, D Mahajan, J Coombs, Y M Wang, S I Alexander, D C H Harris.   

Abstract

Macrophage infiltration of the kidney is a prominent feature associated with the severity of renal injury and progressive renal failure. To determine the influence of macrophages in renal disease models in the absence of endogenous T and B cells, we performed adoptive transfer of macrophages into severe combined immunodeficient (SCID) mice. In this study, macrophages were isolated from the spleens of BALB/c mice and stimulated with lipopolysaccharide to induce classically activated M1 macrophages or with interleukin-4 (IL-4) and IL-13 to induce alternatively activated M2 macrophages. These macrophages were then infused into SCID mice with adriamycin nephropathy; an in vivo model of chronic inflammatory renal disease analogous to human focal segmental glomerulosclerosis. Mice infused with M1 macrophages had a more severe histological and functional injury, whereas M2 macrophage-induced transfused mice had reduced histological and functional injury. Both M1 and M2 macrophages localized preferentially to the area of injury and maintained their phenotypes even after 4 weeks. The protective effect of M2 macrophages was associated with reduced accumulation and possibly downregulated chemokine and inflammatory cytokine expression of the host infiltrating macrophages. Our findings demonstrate that macrophages not only act as effectors of immune injury but can be induced to provide protection against immune injury.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17440493     DOI: 10.1038/sj.ki.5002275

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  134 in total

1.  MyD88 signaling pathway is involved in renal fibrosis by favoring a TH2 immune response and activating alternative M2 macrophages.

Authors:  Tarcio Teodoro Braga; Matheus Correa-Costa; Yuri Felipe Souza Guise; Angela Castoldi; Cassiano Donizetti de Oliveira; Meire Ioshie Hyane; Marcos Antonio Cenedeze; Simone Aparecida Teixeira; Marcelo Nicolas Muscara; Katia Regina Perez; Iolanda Midea Cuccovia; Alvaro Pacheco-Silva; Giselle Martins Gonçalves; Niels Olsen Saraiva Camara
Journal:  Mol Med       Date:  2012-10-24       Impact factor: 6.354

Review 2.  Macrophage polarization in pathology.

Authors:  Antonio Sica; Marco Erreni; Paola Allavena; Chiara Porta
Journal:  Cell Mol Life Sci       Date:  2015-07-26       Impact factor: 9.261

3.  Distinct macrophage phenotypes contribute to kidney injury and repair.

Authors:  Sik Lee; Sarah Huen; Hitoshi Nishio; Saori Nishio; Heung Kyu Lee; Bum-Soon Choi; Christiana Ruhrberg; Lloyd G Cantley
Journal:  J Am Soc Nephrol       Date:  2011-02       Impact factor: 10.121

Review 4.  Phenotypic transitions of macrophages orchestrate tissue repair.

Authors:  Margaret L Novak; Timothy J Koh
Journal:  Am J Pathol       Date:  2013-09-30       Impact factor: 4.307

Review 5.  Targeting the progression of chronic kidney disease.

Authors:  Marta Ruiz-Ortega; Sandra Rayego-Mateos; Santiago Lamas; Alberto Ortiz; Raul R Rodrigues-Diez
Journal:  Nat Rev Nephrol       Date:  2020-02-14       Impact factor: 28.314

6.  Pentraxin-3 Attenuates Renal Damage in Diabetic Nephropathy by Promoting M2 Macrophage Differentiation.

Authors:  Huaibin Sun; Jun Tian; Wanhua Xian; Tingting Xie; Xiangdong Yang
Journal:  Inflammation       Date:  2015-10       Impact factor: 4.092

7.  Impaired apoptotic cell clearance in CGD due to altered macrophage programming is reversed by phosphatidylserine-dependent production of IL-4.

Authors:  Ruby F Fernandez-Boyanapalli; S Courtney Frasch; Kathleen McPhillips; R William Vandivier; Brian L Harry; David W H Riches; Peter M Henson; Donna L Bratton
Journal:  Blood       Date:  2008-10-24       Impact factor: 22.113

8.  Macrophage A2A Adenosine Receptors Are Essential to Protect from Progressive Kidney Injury.

Authors:  Luan D Truong; Jessica Trostel; Rachel McMahan; Jiang-Fan Chen; Gabriela E Garcia
Journal:  Am J Pathol       Date:  2016-08-09       Impact factor: 4.307

Review 9.  Macrophage diversity in renal injury and repair.

Authors:  Sharon D Ricardo; Harry van Goor; Allison A Eddy
Journal:  J Clin Invest       Date:  2008-11       Impact factor: 14.808

Review 10.  The Pathogenesis and Therapeutic Implications of Tubulointerstitial Inflammation in Human Lupus Nephritis.

Authors:  Marcus R Clark; Kimberly Trotter; Anthony Chang
Journal:  Semin Nephrol       Date:  2015-09       Impact factor: 5.299

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.